Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Global Longlife Hospital & Research Current Ratio?
Global Longlife Hospital & ResearchBOM:543520 -1.81%36 Current Ratio is 1,691.15 as of Mar. 2026, which is 143218% above its 10-year median of 1.18. GuruFocus rates BOM:543520 with a GF Score™ of 36/100 and a GF Value™ of ₹1.37 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 680 Healthcare Providers & Services companies, Global Longlife Hospital & Research ranks better than 99.85% on this metric.
BOM:543520'
s Current Ratio Range Over the Past 10 Years
Min: 0.32 Med: 1.18 Max: 1691.15
Current: 1691.15
During the past 8 years, Global Longlife Hospital & Research's highest Current Ratio was 1691.15. The lowest was 0.32. And the median was 1.18.
BOM:543520's Current Ratio is ranked better than 99.85% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs BOM:543520: 1691.15
Global Longlife Hospital & Research (BOM:543520) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Global Longlife Hospital & Research Current Ratio Related Terms
Global Longlife Hospital & Research Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Longlife Hospital & Research Current Ratio Chart
BOM:543520 vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Longlife Hospital & Research Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's Current Ratio distribution charts can be found below:
* The bar in red indicates where Global Longlife Hospital & Research's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Longlife Hospital & Research (BOM:543520) has a Current Ratio of 1,691.15 as of Mar. 2026. This is 143218% above median its historical median of 1.18. Over the past decade, Global Longlife Hospital & Research's Current Ratio has ranged from 0.32 to 1,691.15. According to the industry distribution chart, Global Longlife Hospital & Research ranks #1 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 0.099999999999994%.
Is Global Longlife Hospital & Research's Current Ratio too high?
Global Longlife Hospital & Research's current Current Ratio of 1,691.15 is 143218% above median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 1,691.15. The Healthcare Providers & Services industry median Current Ratio is 1.47. Global Longlife Hospital & Research's value of 1,691.15 is 114944.2% above this industry median. Based on the distribution chart, Global Longlife Hospital & Research ranks #1 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Global Longlife Hospital & Research has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Global Longlife Hospital & Research's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Longlife Hospital & Research ranks #1 out of 680 companies for Current Ratio. This places Global Longlife Hospital & Research in the top 0% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Global Longlife Hospital & Research's value of 1,691.15 is 114944.2% above this benchmark. Historically, Global Longlife Hospital & Research's own Current Ratio has ranged from 0.32 to 1,691.15 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 1.47, Global Longlife Hospital & Research has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Longlife Hospital & Research's current Current Ratio of 1,691.15 is 114944.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Longlife Hospital & Research's current Current Ratio is 1,691.15, which is 143218% above median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Longlife Hospital & Research stock overvalued right now?
Based on GuruFocus' analysis, Global Longlife Hospital & Research (BOM:543520) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.37, compared to a current price of ₹13.04 — trading 851.8% above its estimated fair value. The current Current Ratio is 1,691.15, which is 143218% above median its 10-year median of 1.18 and 114944.2% above the Healthcare Providers & Services industry median of 1.47. Global Longlife Hospital & Research's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Global Longlife Hospital & Research (BOM:543520), the current Current Ratio is 1,691.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Longlife Hospital & Research (BOM:543520) Overvalued in 2026?
Based on GuruFocus' analysis, Global Longlife Hospital & Research stock appears to be overvalued.
The current stock price of ₹13.04 is trading 851.8% above its estimated GF Value™ of ₹1.37.
GuruFocus considers Global Longlife Hospital & Research to be Significantly Overvalued.
Key valuation signals for BOM:543520:
Current Ratio: 1,691.15 (143218% above median its 10-year median of 1.18)
GF Value™: ₹1.37 vs. price of ₹13.04 (851.8% above fair value)
Industry Position: 114944.2% above the Healthcare Providers & Services median (#1 of 680)
No single metric tells the full story. See the BOM:543520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Longlife Hospital & Research Ltd is Multispecialty Hospital providing Medical & Allied Services. The company operates in the single segment i.e. Health Care and Hospital. Its services are Medical, Surgical, Radiology, Pathology, and Other Services.
36GF Score
Get the complete analysis for BOM:543520
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543520 has been successfully added to your 
